Glenmark Pharmaceuticals informs about media release

23 Jan 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark launches AKYNZEO® I.V. in India – First Fixed I.V. Antiemetic Combination for the Prevention of Chemotherapyinduced Nausea and Vomiting’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1999.35 -1.25 (-0.06%)
19-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1655.00
Dr. Reddys Lab 1173.30
Cipla 1383.80
Zydus Lifesciences 858.45
Lupin 2153.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×